Azurity Pharmaceuticals sued Alkem Laboratories alleging Alkem’s Abbreviated New Drug Application (“ANDA”) infringed a patent directed to drinkable drugs for treating colon infections.

Alkem Laboratories Ltd. ( (IN:ALKEM)) has shared an update. Alkem Laboratories Ltd. announced the completion of its acquisition of a 100% stake in Bombay Ortho Industries Private Limited through ...

Alkem Laboratories Ltd. affirming the District of Delaware’s ruling that Alkem’s generic drinkable antibiotic product did not infringe patent claims owned by Azurity Pharmaceuticals.